Search Results

There are 4943 results for: content related to: Acute haemodynamic response in relation to plasma vardenafil concentrations in patients with pulmonary hypertension

  1. Vardenafil Improves Penile Erection in Type 2 Diabetes Mellitus Patients with Erectile Dysfunction: Role of Tropomyosin

    The Journal of Sexual Medicine

    Volume 10, Issue 12, December 2013, Pages: 3110–3120, Jose J. Zamorano-León, Carlos Olivier, Natalia de las Heras, Petra J. Mateos-Cáceres, Ricardo Brime Menéndez, Pablo Rodríguez-Sierra, Naihara Martín Palacios, Luis San José Manso, Javier Modrego, Antonio Segura, Carlos Macaya and Antonio J. López-Farré

    Version of Record online : 24 SEP 2013, DOI: 10.1111/jsm.12324

  2. The Clinical Pharmacokinetics of Phosphodiesterase-5 Inhibitors for Erectile Dysfunction

    The Journal of Clinical Pharmacology

    Volume 45, Issue 9, September 2005, Pages: 987–1003, Dr Manish Gupta, Dr Andreas Kovar and Dr Bernd Meibohm

    Version of Record online : 19 MAR 2013, DOI: 10.1177/0091270005276847

  3. Effect of High-Fat Breakfast and Moderate-Fat Evening Meal on the Pharmacokinetics of Vardenafil, an Oral Phosphodiesterase-5 Inhibitor for the Treatment of Erectile Dysfunction

    The Journal of Clinical Pharmacology

    Volume 43, Issue 3, March 2003, Pages: 260–267, Dr. Prabhu Rajagopalan, Dr. Arthur Mazzu, Dr. Chenghua Xia, Dr. Ray Dawkins and Dr. Pavur Sundaresan

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270002250604

  4. Vardenafil Modulates Bladder Contractility Through cGMP-mediated Inhibition of RhoA/Rho Kinase Signaling Pathway in Spontaneously Hypertensive Rats

    The Journal of Sexual Medicine

    Volume 6, Issue 6, June 2009, Pages: 1594–1608, Annamaria Morelli, Sandra Filippi, Peter Sandner, Benedetta Fibbi, Aravinda K. Chavalmane, Enrico Silvestrini, Erica Sarchielli, Linda Vignozzi, Mauro Gacci, Marco Carini, Gabriella B. Vannelli and Mario Maggi

    Version of Record online : 30 MAR 2009, DOI: 10.1111/j.1743-6109.2009.01249.x

  5. Characterization of efflux transport of the PDE5 inhibitors, vardenafil and sildenafil

    Journal of Pharmacy and Pharmacology

    Volume 64, Issue 8, August 2012, Pages: 1074–1083, Min-Koo Choi and Im-Sook Song

    Version of Record online : 16 MAR 2012, DOI: 10.1111/j.2042-7158.2012.01498.x

  6. Effect of vardenafil on nitric oxide synthase expression in the paraventricular nucleus of rats without sexual stimulation

    Andrologia

    Volume 44, Issue s1, May 2012, Pages: 56–67, M.-S. Shin, I.-G. Ko, S.-E. Kim, B.-K. Kim, C.-J. Kim, D.-H. Kim, S.-J. Yoon and K.-H. Kim

    Version of Record online : 24 SEP 2011, DOI: 10.1111/j.1439-0272.2010.01138.x

  7. Global experiences with vardenafil in men with erectile dysfunction and underlying conditions

    International Journal of Clinical Practice

    Volume 62, Issue 10, October 2008, Pages: 1594–1603, I. Eardley, J. C. Lee and A. T. Guay

    Version of Record online : 8 SEP 2008, DOI: 10.1111/j.1742-1241.2008.01852.x

  8. Earliest Time to Onset of Action Leading to Successful Intercourse with Vardenafil Determined in an At-Home Setting: A Randomized, Double-Blind, Placebo-Controlled Trial

    The Journal of Sexual Medicine

    Volume 1, Issue 2, September 2004, Pages: 168–178, Francesco Montorsi, Harin Padma-Nathan, Jacques Buvat, Hartwig Schwaibold, Manfred Beneke, Ernst Ulbrich, Tiemo-Joerg Bandel, Hartmut Porst and the Vardenafil Study Group

    Version of Record online : 13 SEP 2004, DOI: 10.1111/j.1743-6109.2004.04025.x

  9. You have free access to this content
    Erectile response with vardenafil in sildenafil nonresponders: a multicentre, double-blind, 12-week, flexible-dose, placebo-controlled erectile dysfunction clinical trial

    BJU International

    Volume 94, Issue 9, December 2004, Pages: 1301–1309, Culley C. Carson, Dimitrios G. Hatzichristou, Serge Carrier, Douglas Lording, Peter Lyngdorf, Philip Aliotta, Stephen Auerbach, Myron Murdock, H. Jeffrey Wilkins, Trish A. McBride and Michael W. Colopy

    Version of Record online : 6 DEC 2004, DOI: 10.1111/j.1464-410X.2004.05161.x

  10. Comparison of Pharmacokinetics of Vardenafil Administered Using an Ultrasonic Nebulizer for Inhalation vs. a Single 10-mg Oral Tablet

    The Journal of Sexual Medicine

    Brooke Berry, Phillip Altman, James Rowe and Jack Vaisman

    Version of Record online : 28 JUL 2009, DOI: 10.1111/j.1743-6109.2009.01403.x

  11. You have free access to this content
    Safety and efficacy of vardenafil in patients with erectile dysfunction: Result of a bridging study in Japan

    International Journal of Urology

    Volume 11, Issue 7, July 2004, Pages: 515–524, KOICHI NAGAO, NOBUHISA ISHII, SADAO KAMIDONO, TAKAO OSADA and THE VARDENAFIL (LEVITRA) CLINICAL TRIAL GROUP

    Version of Record online : 7 JUL 2004, DOI: 10.1111/j.1442-2042.2004.00833.x

  12. Vardenafil Restores Erectile Function to Normal Range in Men with Erectile Dysfunction

    The Journal of Sexual Medicine

    Volume 4, Issue 1, January 2007, Pages: 152–161, Harin Padma-Nathan, Francesco Montorsi, François Giuliano, Eric Meuleman, Stephen Auerbach, Ian Eardley, Andrew McCullough, Martin Homering, Thomas Segerson and for the North American and European Vardenafil Study Group

    Version of Record online : 3 JAN 2007, DOI: 10.1111/j.1743-6109.2006.00380.x

  13. Time to Onset of Action of Vardenafil: A Retrospective Analysis of the Pivotal Trials for the Orodispersible and Film-Coated Tablet Formulations

    The Journal of Sexual Medicine

    Volume 8, Issue 10, October 2011, Pages: 2912–2923, Frans M.J. Debruyne, Marc Gittelman, Herbert Sperling, Matthias Börner and Manfred Beneke

    Version of Record online : 30 AUG 2011, DOI: 10.1111/j.1743-6109.2011.02462.x

  14. You have free access to this content
    Vardenafil in Patients With Erectile Dysfunction: Achieving Treatment Optimization

    Journal of Andrology

    Volume 26, Issue 5, September-October 2005, Pages: 604–609, Wayne J. G. Hellstrom, Mostafa Elhilali, Martin Homering, Terry Taylor and Marc Gittleman

    Version of Record online : 2 JAN 2013, DOI: 10.2164/jandrol.05026

  15. You have full text access to this Open Access content
    PDE5 inhibitors, sildenafil and vardenafil, reverse multidrug resistance by inhibiting the efflux function of multidrug resistance protein 7 (ATP-binding Cassette C10) transporter

    Cancer Science

    Volume 103, Issue 8, August 2012, Pages: 1531–1537, Jun-Jiang Chen, Yue-Li Sun, Amit K. Tiwari, Zhi-Jie Xiao, Kamlesh Sodani, Dong-Hua Yang, Saraubh G. Vispute, Wen-Qi Jiang, Si-Dong Chen and Zhe-Sheng Chen

    Version of Record online : 6 JUL 2012, DOI: 10.1111/j.1349-7006.2012.02328.x

  16. You have free access to this content
    The POTENT II randomised trial: efficacy and safety of an orodispersible vardenafil formulation for the treatment of erectile dysfunction

    International Journal of Clinical Practice

    Volume 64, Issue 5, April 2010, Pages: 594–603, M. Gittelman, C. G. McMahon, J. A. Rodríguez-Rivera, M. Beneke, E. Ulbrich and S. Ewald

    Version of Record online : 4 MAR 2010, DOI: 10.1111/j.1742-1241.2010.02358.x

  17. Vardenafil Improves Erectile Function in Men with Erectile Dysfunction Irrespective of Disease Severity and Disease Classification

    The Journal of Sexual Medicine

    Volume 1, Issue 3, November 2004, Pages: 301–309, Craig Donatucci, Ian Eardley, Jacques Buvat, Marc Gittelman, Phillip Kell, Thom Segerson, Martin Homering, Francesco Montorsi and for the Vardenafil Study Group

    Version of Record online : 13 OCT 2004, DOI: 10.1111/j.1743-6109.04043.x

  18. Duration of Erection: Does It Really Matter? A Randomized, Double-Blind Clinical Trial to Assess the Impact of Vardenafil ODT on Duration of Erection and Its Correlation with Patients' and Partners' Sexual Quality of Life and Duration of Intercourse: The VADEOPEN Study

    The Journal of Sexual Medicine

    Volume 11, Issue 6, June 2014, Pages: 1527–1538, Antonio Martin-Morales, Pedro Gutiérrez-Hernández, Javier Romero-Otero, José A. Romero-Martín and on behalf of the Vadeopen Study Group

    Version of Record online : 13 MAR 2014, DOI: 10.1111/jsm.12496

  19. You have free access to this content
    The phosphodiesterase-5 inhibitor vardenafil improves cardiovascular dysfunction in experimental diabetes mellitus

    British Journal of Pharmacology

    Volume 156, Issue 6, March 2009, Pages: 909–919, T Radovits, T Bömicke, G Kökény, R Arif, S Loganathan, K Kécsán, S Korkmaz, E Barnucz, P Sandner, M Karck and G Szabó

    Version of Record online : 4 MAR 2009, DOI: 10.1111/j.1476-5381.2008.00098.x

  20. You have free access to this content
    Vardenafil is effective and well-tolerated for treating erectile dysfunction in a broad population of men, irrespective of age

    BJU International

    Volume 95, Issue 1, January 2005, Pages: 110–116, François Giuliano, Craig Donatucci, Francesco Montorsi, Stephen Auerbach, Gary Karlin, Christiane Norenberg, Martin Homering, Thomas Segerson, Ian Eardley and Vardenafil Study Group

    Version of Record online : 20 DEC 2004, DOI: 10.1111/j.1464-410X.2004.05260.x